Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodney J Ellis

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Brachytherapy|April 6, 2004
Combination conformal radiotherapy and radioimmunoguided transperineal 103Pd implantation for patients with intermediate and unfavorable risk prostate adenocarcinomaRodney J Ellis, Amy Vertocnik, Bruce Sodee, et al.
Brachytherapy|April 17, 2007
Rectal morbidity after permanent prostate brachytherapy with dose escalation to biologic target volumes identified by SPECT/CT fusionRodney J Ellis, Hang Zhou, Deborah A Kaminsky, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 13, 2015
Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinomaLee Ponsky, Simon S Lo, Yuxia Zhang, et al.
Future Oncology (London, England)|September 17, 2011
Stereotactic body radiation therapy for prostate cancerHiromichi Ishiyama, Bin S Teh, Simon S Lo, et al.
Brachytherapy|February 8, 2007
Biochemical disease-free survival rates following definitive low-dose-rate prostate brachytherapy with dose escalation to biologic target volumes identified with SPECT/CT capromab pendetideRodney J Ellis, Hang Zhou, Edward Y Kim, et al.
Expert Review of Anticancer Therapy|April 9, 2013
Emerging role of stereotactic body radiotherapy in the treatment of pancreatic cancerBetul Berber, Juan R Sanabria, Kelly Braun, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2003
Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinomaRodney J Ellis, Amy Vertocnik, Edward Kim, et al.
Future Oncology (London, England)|June 21, 2014
Emerging applications of stereotactic body radiotherapySimon S Lo, Andrew Loblaw, Eric L Chang, et al.
International Journal of Radiation Oncology, Biology, Physics|June 10, 2008
Radiotherapy and survival in prostate cancer patients: a population-based studyEsther H Zhou, Rodney J Ellis, Edward Cherullo, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics|March 17, 2020
Transforming UTE-mDixon MR Abdomen-Pelvis Images Into CT by Jointly Leveraging Prior Knowledge and Partial SupervisionPengjiang Qian, Jiamin Zheng, Qiankun Zheng, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Brachytherapy|April 6, 2004
Combination conformal radiotherapy and radioimmunoguided transperineal 103Pd implantation for patients with intermediate and unfavorable risk prostate adenocarcinomaRodney J Ellis, Amy Vertocnik, Bruce Sodee, et al.
Brachytherapy|April 17, 2007
Rectal morbidity after permanent prostate brachytherapy with dose escalation to biologic target volumes identified by SPECT/CT fusionRodney J Ellis, Hang Zhou, Deborah A Kaminsky, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 13, 2015
Phase I dose-escalation study of stereotactic body radiotherapy (SBRT) for poor surgical candidates with localized renal cell carcinomaLee Ponsky, Simon S Lo, Yuxia Zhang, et al.
Future Oncology (London, England)|September 17, 2011
Stereotactic body radiation therapy for prostate cancerHiromichi Ishiyama, Bin S Teh, Simon S Lo, et al.
Brachytherapy|February 8, 2007
Biochemical disease-free survival rates following definitive low-dose-rate prostate brachytherapy with dose escalation to biologic target volumes identified with SPECT/CT capromab pendetideRodney J Ellis, Hang Zhou, Edward Y Kim, et al.
Expert Review of Anticancer Therapy|April 9, 2013
Emerging role of stereotactic body radiotherapy in the treatment of pancreatic cancerBetul Berber, Juan R Sanabria, Kelly Braun, et al.
International Journal of Radiation Oncology, Biology, Physics|September 6, 2003
Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinomaRodney J Ellis, Amy Vertocnik, Edward Kim, et al.
Future Oncology (London, England)|June 21, 2014
Emerging applications of stereotactic body radiotherapySimon S Lo, Andrew Loblaw, Eric L Chang, et al.
International Journal of Radiation Oncology, Biology, Physics|June 10, 2008
Radiotherapy and survival in prostate cancer patients: a population-based studyEsther H Zhou, Rodney J Ellis, Edward Cherullo, et al.
IEEE/ACM Transactions on Computational Biology and Bioinformatics|March 17, 2020
Transforming UTE-mDixon MR Abdomen-Pelvis Images Into CT by Jointly Leveraging Prior Knowledge and Partial SupervisionPengjiang Qian, Jiamin Zheng, Qiankun Zheng, et al.
Pageof 5